INSYNC GLOBAL TITANS FUND
Attached is our most recently updated Fund Review on the Insync Global Titans Fund.
We would like to highlight the following:
-
The Fund outperformed its benchmark MSCI All Country World ex-Australia Net Total Return Index ($A) by 1.0%, in July. The performance was fairly broadly based across the portfolio, with the biggest positive contributions coming from the holdings in eBay, Reckitt Benckiser, Sanofi, BAT and Medtronic. A small negative contribution came from their holding in Zimmer. The Fund continues to have no foreign currency hedging in place as Insync consider the main risks to the Australian dollar to be on the downside.
-
The Global Titans Fund invests in a concentrated portfolio of 15-30 stocks, targeting exceptional, large cap global companies with a strong focus on dividend growth and downside protection.
-
Portfolio selection is driven by a core strategy of investing in companies with sustainable growth in dividends, high returns on capital, positive free cash flows and strong balance sheets.
-
Emphasis on limiting downside risk is through extensive company research, the ability to hold cash and long protective index put options.
For further details on the Fund, please do not hesitate to contact us.
Australian Fund Monitors
Insync Global Titans Fund AFM Fund Review July 2015 (pdf format)
